Alkermes plc.: insider trading
2,662 trades by 36 directors, officers and 10% owners since 2011, from their SEC Form 4 and 5 filings.
Bought, 12 months
$0
0 purchases by 0 insiders
Sold, 12 months
$10.1 M
33 sales by 7 insiders
Bought, 3 months
$0
0 purchases
Sold, 3 months
$698 K
4 sales
Insider buying and selling by month
Open-market purchases and sales by value, last three years.
Insiders (36)
Each insider's latest direct holding and their open-market trades of the last 12 months, most recent first.
| Insider | Shares owned directly | Bought, 12 m | Sold, 12 m | Latest trade |
|---|---|---|---|---|
| David Joseph GaffinEVP, CLO, Alkermes, Inc. | 219,353 | — | $829 K | |
| Joshua ReedSVP, Chief Financial Officer | 5,095 | — | — | |
| Craig C. HopkinsonEVP R&D, Chief Medical Officer | 65,389 | — | $3.4 M | |
| Christian Todd NicholsSVP, Chief Commercial Officer | 102,193 | — | $553 K | |
| Nancy Lynn SnydermanDirector | 15,395 | — | $2.2 M | |
| Christopher I. WrightDirector | 25,680 | — | $90 K | |
| Samuel Joseph ParisiVP, Finance (Interim PAO) | 7,717 | — | $889 K | |
| Brian P. McKeonDirector | 38,536 | — | — | |
| Cato T. LaurencinDirector | 33,769 | — | — | |
| Frank Anders WilsonDirector | 35,751 | — | — | |
| Nancy LurkerDirector | 18,222 | — | — | |
| Richard GaynorDirector | 35,751 | — | — | |
| Shane CookeDirector | 106,679 | — | $2.1 M | |
| Blair Curtis JacksonEVP, Chief Operating Officer | 241,308 | — | — | |
| Richard F. PopsDirector and CEO, Alkermes plc, Director | 1.38 M | — | — | |
| Iain Michael BrownSVP, Chief Financial Officer | 148,196 | — | — | |
| David Angelo Daglio Jr.Director | 27,780 | — | — | |
| Emily Peterson AlvaDirector | 27,302 | — | — | |
| Michael J. LandineSVP, Corp Dev., Alkermes, Inc. | 281,730 | — | — | |
| Nancy WysenskiDirector | 20,356 | — | — | |
| David W. AnsticeDirector | 84,905 | — | — | |
| Wendy L. DixonDirector | 53,124 | — | — | |
| Paul J. MitchellDirector | 11,174 | — | — | |
| Robert A. BreyerDirector | 10,330 | — | — | |
| James M. FratesSVP, Alks Inc; CFO ALKS | 91,828 | — | — | |
| James A. Robinson Jr.President & COO,Alkermes, Inc. | 4,412 | — | — | |
| Floyd E. BloomDirector | 128,881 | — | — | |
| Kathryn L. BibersteinEVP/CAO/CCO/CRO Alks Inc | 40,200 | — | — | |
| Mark StejbachSVP/Chief Comm Off, Alks Inc | 51,065 | — | — | |
| Elliot EhrichEVP, R&D & CMO, Alkermes, Inc. | 57,056 | — | — | |
| Gordon G. PughSVP, COO & CRO, Alkermes, Inc. | 20,587 | — | — | |
| Rebecca PetersonSVP, Corporate Communications | 2,644 | — | — | |
| Geraldine HenwoodDirector | 0 | — | — | |
| James L. BotkinSVP, Alkermes Gainesville LLC | 2,509 | — | — | |
| Elan Science Three Ltd10% owner | — | — | — | |
| Mark B. SkaletskyDirector | 0 | — | — |
Trades#
The newest 300 trades.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sell10b5-1 plan | -2,035 | $46.17 | $94 K | 219,353 | Form 4 |
| filed | Joshua ReedSVP, Chief Financial Officer | Option exercise | +9,164 | — | — | 9,164 | Form 4 |
| filed | Joshua ReedSVP, Chief Financial Officer | Shares withheld for tax | -4,069 | $40.11 | $163 K | 5,095 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sell10b5-1 plan | -2,034 | $41.03 | $83 K | 221,388 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sell10b5-1 plan | -2,034 | $48.01 | $98 K | 223,422 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +5,000 | $24.59 | $123 K | 74,389 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -9,000 | $46.99 | $423 K | 65,389 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Sell10b5-1 plan | -6,912 | $49.19 | $340 K | 102,857 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Sell10b5-1 plan | -664 | $49.65 | $33 K | 102,193 | Form 4 |
| filed | Nancy Lynn SnydermanDirector | Option exercise | +27,948 | $46.72 | $1.3 M | 43,343 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +104 | $19.34 | $2 K | 73,493 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sell10b5-1 plan | -2,034 | $48.58 | $99 K | 225,456 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +4,896 | $24.59 | $120 K | 78,389 | Form 4 |
| filed | Nancy Lynn SnydermanDirector | Option exercise | +16,524 | $46.72 | $772 K | 59,867 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -9,000 | $48.58 | $437 K | 69,389 | Form 4 |
| filed | Nancy Lynn SnydermanDirector | Sell | -44,472 | $50.35 | $2.2 M | 15,395 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sell10b5-1 plan | -2,034 | $54.03 | $110 K | 227,490 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +5,000 | $19.34 | $97 K | 82,389 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -8,300 | $51.46 | $427 K | 74,089 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -700 | $52.13 | $36 K | 73,389 | Form 4 |
| filed | Christopher I. WrightDirector | Sell10b5-1 plan | -2,000 | $45.10 | $90 K | 25,680 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sell10b5-1 plan | -2,034 | $43.05 | $88 K | 229,524 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +5,000 | $19.34 | $97 K | 86,389 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -9,000 | $41.67 | $375 K | 77,389 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise | +3,392 | $20.03 | $68 K | 11,109 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise | +12,825 | $19.34 | $248 K | 23,934 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Sell | -16,217 | $42.36 | $687 K | 7,717 | Form 4 |
| filed | Frank Anders WilsonDirector | Option exercise | +6,142 | — | — | 37,226 | Form 4 |
| filed | Cato T. LaurencinDirector | Option exercise | +6,142 | — | — | 35,244 | Form 4 |
| filed | Christopher I. WrightDirector | Option exercise | +6,142 | — | — | 29,155 | Form 4 |
| filed | Nancy Lynn SnydermanDirector | Option exercise | +6,142 | — | — | 16,870 | Form 4 |
| filed | Nancy LurkerDirector | Option exercise | +6,142 | — | — | 19,697 | Form 4 |
| filed | Richard GaynorDirector | Option exercise | +6,142 | — | — | 37,226 | Form 4 |
| filed | Shane CookeDirector | Option exercise | +6,142 | — | — | 109,886 | Form 4 |
| filed | Brian P. McKeonDirector | Option exercise | +6,142 | — | — | 40,011 | Form 4 |
| filed | Nancy Lynn SnydermanDirector | Shares withheld for tax | -1,475 | $36.95 | $55 K | 15,395 | Form 4 |
| filed | Nancy LurkerDirector | Shares withheld for tax | -1,475 | $36.95 | $55 K | 18,222 | Form 4 |
| filed | Brian P. McKeonDirector | Shares withheld for tax | -1,475 | $36.95 | $55 K | 38,536 | Form 4 |
| filed | Cato T. LaurencinDirector | Shares withheld for tax | -1,475 | $36.95 | $55 K | 33,769 | Form 4 |
| filed | Christopher I. WrightDirector | Shares withheld for tax | -1,475 | $36.95 | $55 K | 27,680 | Form 4 |
| filed | Frank Anders WilsonDirector | Shares withheld for tax | -1,475 | $36.95 | $55 K | 35,751 | Form 4 |
| filed | Richard GaynorDirector | Shares withheld for tax | -1,475 | $36.95 | $55 K | 35,751 | Form 4 |
| filed | Shane CookeDirector | Shares withheld for tax | -3,207 | $36.95 | $118 K | 106,679 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sell10b5-1 plan | -2,034 | $33.20 | $68 K | 231,558 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +5,000 | $19.34 | $97 K | 90,389 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -9,000 | $33.40 | $301 K | 81,389 | Form 4 |
| filed | Nancy LurkerDirector | Option exercise | +3,751 | — | — | 14,456 | Form 4 |
| filed | Nancy LurkerDirector | Shares withheld for tax | -901 | $33.36 | $30 K | 13,555 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sell10b5-1 plan | -2,034 | $34.57 | $70 K | 233,592 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +5,000 | $19.34 | $97 K | 94,389 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -9,000 | $35.51 | $320 K | 85,389 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sell10b5-1 plan | -2,034 | $29.76 | $61 K | 235,626 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Sell10b5-1 plan | -6,890 | $29.29 | $202 K | 7,717 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Sell10b5-1 plan | -6,000 | $30.00 | $180 K | 109,769 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Sell10b5-1 plan | -2,034 | $29.29 | $60 K | 237,660 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +5,000 | $19.34 | $97 K | 98,389 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -9,000 | $29.72 | $267 K | 89,389 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Option exercise | +5,410 | — | — | 118,172 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option exercise | +6,866 | — | — | 242,743 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise | +2,747 | — | — | 15,415 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Option exercise | +8,322 | — | — | 245,003 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise | +6,866 | — | — | 96,438 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Shares withheld for tax | -808 | $30.73 | $25 K | 14,607 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Shares withheld for tax | -2,403 | $30.73 | $74 K | 115,769 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Shares withheld for tax | -3,049 | $30.73 | $94 K | 93,389 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Shares withheld for tax | -3,695 | $30.73 | $114 K | 241,308 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -3,049 | $30.73 | $94 K | 239,694 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Option exercise | +6,407 | — | — | 115,607 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise | +2,283 | — | — | 13,340 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option exercise | +7,689 | — | — | 239,291 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Option exercise | +8,738 | — | — | 240,561 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise | +7,689 | — | — | 92,986 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Shares withheld for tax | -3,880 | $32.19 | $125 K | 236,681 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Shares withheld for tax | -3,414 | $32.19 | $110 K | 89,572 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Shares withheld for tax | -2,845 | $32.19 | $92 K | 112,762 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -3,414 | $32.19 | $110 K | 235,877 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Shares withheld for tax | -672 | $32.19 | $22 K | 12,668 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Option exercise | +9,300 | — | — | 235,953 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option exercise | +7,673 | — | — | 235,009 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise | +7,673 | — | — | 88,704 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Option exercise | +6,045 | — | — | 111,477 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise | +2,991 | — | — | 12,036 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Shares withheld for tax | -2,277 | $32.00 | $73 K | 109,200 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Shares withheld for tax | -4,130 | $32.00 | $132 K | 231,823 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Shares withheld for tax | -979 | $32.00 | $31 K | 11,057 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -3,407 | $32.00 | $109 K | 231,602 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Shares withheld for tax | -3,407 | $32.00 | $109 K | 85,297 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Option exercise | +6,355 | — | — | 107,301 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise | +8,897 | — | — | 84,535 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Option exercise | +8,897 | — | — | 230,449 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise | +2,034 | — | — | 9,751 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option exercise | +6,355 | — | — | 229,462 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Shares withheld for tax | -3,504 | $32.02 | $112 K | 81,031 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Shares withheld for tax | -3,796 | $32.02 | $122 K | 226,653 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Shares withheld for tax | -1,869 | $32.02 | $60 K | 105,432 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -2,126 | $32.02 | $68 K | 227,336 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Shares withheld for tax | -706 | $32.02 | $23 K | 9,045 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Grant or award | +25,352 | — | — | 230,726 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Grant or award | +28,810 | — | — | 230,178 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Grant or award | +25,352 | — | — | 83,092 | Form 4 |
| filed | Richard F. PopsDirector and CEO, Alkermes plc, Director | Grant or award | +149,580 | — | — | 1.44 M | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Grant or award | +21,127 | — | — | 107,335 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -7,619 | $33.55 | $256 K | 223,107 | Form 4 |
| filed | Richard F. PopsDirector and CEO, Alkermes plc, Director | Shares withheld for tax | -62,230 | $33.55 | $2.1 M | 1.38 M | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Shares withheld for tax | -6,389 | $33.55 | $214 K | 100,946 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Shares withheld for tax | -8,626 | $33.55 | $289 K | 221,552 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Shares withheld for tax | -7,454 | $33.55 | $250 K | 75,638 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +5,000 | $19.34 | $97 K | 66,740 | Form 4 |
| filed | Shane CookeDirector | Option exercise10b5-1 plan | +61,200 | $31.64 | $1.9 M | 164,944 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -5,000 | $34.24 | $171 K | 61,740 | Form 4 |
| filed | Shane CookeDirector | Sell10b5-1 plan | -29,087 | $34.34 | $999 K | 135,857 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -4,000 | $33.54 | $134 K | 57,740 | Form 4 |
| filed | Shane CookeDirector | Sell10b5-1 plan | -32,113 | $34.78 | $1.1 M | 103,744 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +5,000 | $19.34 | $97 K | 66,740 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -5,000 | $30.00 | $150 K | 61,740 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -4,000 | $28.00 | $112 K | 61,740 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +3,748 | $19.34 | $72 K | 69,488 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -3,748 | $30.00 | $112 K | 65,740 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -4,000 | $29.30 | $117 K | 65,740 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +5,000 | $19.34 | $97 K | 78,740 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -9,000 | $30.38 | $273 K | 69,740 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +5,000 | $19.34 | $97 K | 82,740 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -9,000 | $31.53 | $284 K | 73,740 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option exercise | +2,014 | — | — | 206,269 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -895 | $26.55 | $24 K | 205,374 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Sell10b5-1 plan | -3,334 | $31.09 | $104 K | 86,208 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Sell10b5-1 plan | -3,333 | $31.95 | $106 K | 89,542 | Form 4 |
| filed | Christopher I. WrightDirector | Option exercise | +3,301 | — | — | 23,806 | Form 4 |
| filed | Christopher I. WrightDirector | Shares withheld for tax | -793 | $31.71 | $25 K | 23,013 | Form 4 |
| filed | Richard GaynorDirector | Option exercise | +8,013 | — | — | 33,008 | Form 4 |
| filed | Christopher I. WrightDirector | Option exercise | +8,013 | — | — | 22,429 | Form 4 |
| filed | Shane CookeDirector | Option exercise | +8,013 | — | — | 107,919 | Form 4 |
| filed | Nancy Lynn SnydermanDirector | Option exercise | +8,013 | — | — | 12,652 | Form 4 |
| filed | Nancy LurkerDirector | Option exercise | +8,013 | — | — | 12,629 | Form 4 |
| filed | Frank Anders WilsonDirector | Option exercise | +8,013 | — | — | 33,008 | Form 4 |
| filed | Brian P. McKeonDirector | Option exercise | +8,013 | — | — | 35,793 | Form 4 |
| filed | Cato T. LaurencinDirector | Option exercise | +8,013 | — | — | 31,026 | Form 4 |
| filed | Cato T. LaurencinDirector | Shares withheld for tax | -1,924 | $30.61 | $59 K | 29,102 | Form 4 |
| filed | Richard GaynorDirector | Shares withheld for tax | -1,924 | $30.61 | $59 K | 31,084 | Form 4 |
| filed | Nancy LurkerDirector | Shares withheld for tax | -1,924 | $30.61 | $59 K | 10,705 | Form 4 |
| filed | Christopher I. WrightDirector | Shares withheld for tax | -1,924 | $30.61 | $59 K | 20,505 | Form 4 |
| filed | Brian P. McKeonDirector | Shares withheld for tax | -1,924 | $30.61 | $59 K | 33,869 | Form 4 |
| filed | Shane CookeDirector | Shares withheld for tax | -4,175 | $30.61 | $128 K | 103,744 | Form 4 |
| filed | Frank Anders WilsonDirector | Shares withheld for tax | -1,924 | $30.61 | $59 K | 31,084 | Form 4 |
| filed | Nancy Lynn SnydermanDirector | Shares withheld for tax | -1,924 | $30.61 | $59 K | 10,728 | Form 4 |
| filed | Nancy LurkerDirector | Option exercise | +2,323 | — | — | 2,323 | Form 4 |
| filed | Nancy LurkerDirector | Shares withheld for tax | -558 | $27.00 | $15 K | 1,765 | Form 4 |
| filed | Nancy LurkerDirector | Option exercise | +3,752 | — | — | 5,517 | Form 4 |
| filed | Nancy LurkerDirector | Shares withheld for tax | -901 | $27.00 | $24 K | 4,616 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Sell10b5-1 plan | -1,938 | $34.00 | $66 K | 7,717 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise10b5-1 plan | +2,746 | — | — | 10,463 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Option exercise | +5,409 | — | — | 95,277 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Option exercise | +8,322 | — | — | 205,063 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option exercise | +6,866 | — | — | 207,304 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Option exercise | +5,617 | — | — | 150,690 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise | +6,866 | — | — | 80,789 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Shares withheld for tax | -2,494 | $34.80 | $87 K | 148,196 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -3,049 | $34.80 | $106 K | 204,255 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Shares withheld for tax | -3,049 | $34.80 | $106 K | 77,740 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Shares withheld for tax10b5-1 plan | -808 | $34.80 | $28 K | 9,655 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Shares withheld for tax | -3,695 | $34.80 | $129 K | 201,368 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Shares withheld for tax | -2,402 | $34.80 | $84 K | 92,875 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Sell10b5-1 plan | -3,743 | $35.26 | $132 K | 7,717 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Option exercise | +8,738 | — | — | 200,621 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option exercise | +7,689 | — | — | 203,852 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Option exercise | +6,408 | — | — | 92,714 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise10b5-1 plan | +2,284 | — | — | 12,132 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Option exercise | +5,825 | — | — | 147,660 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise | +7,689 | — | — | 77,337 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Shares withheld for tax | -2,587 | $35.32 | $91 K | 145,073 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Shares withheld for tax | -2,846 | $35.32 | $101 K | 89,868 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -3,414 | $35.32 | $121 K | 200,438 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Shares withheld for tax | -3,880 | $35.32 | $137 K | 196,741 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Shares withheld for tax10b5-1 plan | -672 | $35.32 | $24 K | 11,460 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Shares withheld for tax | -3,414 | $35.32 | $121 K | 73,923 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise | +12,279 | — | — | 75,100 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option exercise | +7,432 | — | — | 199,463 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Option exercise | +7,109 | — | — | 89,463 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise10b5-1 plan | +3,114 | — | — | 10,831 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Option exercise | +7,109 | — | — | 144,989 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Option exercise | +9,694 | — | — | 196,188 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Shares withheld for tax | -4,305 | $35.32 | $152 K | 191,883 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Shares withheld for tax | -3,154 | $35.32 | $111 K | 141,835 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Shares withheld for tax | -5,452 | $35.32 | $193 K | 69,648 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Shares withheld for tax | -3,157 | $35.32 | $112 K | 86,306 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -3,300 | $35.32 | $117 K | 196,163 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Shares withheld for tax10b5-1 plan | -983 | $35.32 | $35 K | 9,848 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Sell10b5-1 plan | -1,327 | $35.69 | $47 K | 7,717 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Option exercise | +6,354 | — | — | 84,223 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise10b5-1 plan | +2,033 | — | — | 9,750 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise | +8,896 | — | — | 66,771 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option exercise | +6,354 | — | — | 194,853 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Option exercise | +6,354 | — | — | 139,749 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Option exercise | +8,896 | — | — | 190,444 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Shares withheld for tax10b5-1 plan | -706 | $35.90 | $25 K | 9,044 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Shares withheld for tax | -3,950 | $35.90 | $142 K | 186,494 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Shares withheld for tax | -1,869 | $35.90 | $67 K | 137,880 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -2,822 | $35.90 | $101 K | 192,031 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Shares withheld for tax | -1,869 | $35.90 | $67 K | 82,354 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Shares withheld for tax | -3,950 | $35.90 | $142 K | 62,821 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +108,833 | $31.93 | $3.5 M | 166,708 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +35,586 | $24.59 | $875 K | 202,294 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -35,586 | $34.02 | $1.2 M | 166,708 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -108,833 | $36.02 | $3.9 M | 57,875 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +87,566 | $20.03 | $1.8 M | 151,166 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +111,630 | $19.34 | $2.2 M | 262,796 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -171,813 | $32.69 | $5.6 M | 90,983 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -33,108 | $33.27 | $1.1 M | 57,875 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Grant or award | +34,393 | — | — | 78,683 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Grant or award | +24,565 | — | — | 85,268 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Grant or award | +34,393 | — | — | 192,195 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Grant or award | +32,350 | — | — | 198,251 | Form 4 |
| filed | Richard F. PopsDirector and CEO, Alkermes plc, Director | Grant or award | +190,640 | — | — | 1.37 M | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Grant or award | +24,565 | — | — | 140,909 | Form 4 |
| filed | Richard F. PopsDirector and CEO, Alkermes plc, Director | Shares withheld for tax | -79,925 | $31.39 | $2.5 M | 1.29 M | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -9,752 | $31.39 | $306 K | 188,499 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Shares withheld for tax | -7,514 | $31.39 | $236 K | 133,395 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Shares withheld for tax | -10,647 | $31.39 | $334 K | 181,548 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Shares withheld for tax | -7,399 | $31.39 | $232 K | 77,869 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Shares withheld for tax | -15,083 | $31.39 | $473 K | 63,600 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +29,156 | $20.03 | $584 K | 76,732 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +26,589 | $19.34 | $514 K | 103,321 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +23,542 | $24.59 | $579 K | 126,863 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +18,345 | $26.82 | $492 K | 145,208 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -100,918 | $32.05 | $3.2 M | 44,290 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +12,452 | $20.03 | $249 K | 72,182 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +12,090 | $19.34 | $234 K | 84,272 | Form 4 |
| filed | Cato T. LaurencinDirector | Option exercise10b5-1 plan | +2,691 | $22.52 | $61 K | 25,704 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +12,044 | $24.59 | $296 K | 96,316 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +12,411 | $26.82 | $333 K | 108,727 | Form 4 |
| filed | Cato T. LaurencinDirector | Sell10b5-1 plan | -2,691 | $31.85 | $86 K | 23,013 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -61,151 | $32.07 | $2.0 M | 47,576 | Form 4 |
| filed | Cato T. LaurencinDirector | Option exercise10b5-1 plan | +4,163 | — | — | 23,971 | Form 4 |
| filed | Cato T. LaurencinDirector | Shares withheld for tax10b5-1 plan | -958 | $31.46 | $30 K | 23,013 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -9,221 | $31.50 | $290 K | 59,730 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -14,349 | $30.77 | $442 K | 68,951 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Sell10b5-1 plan | -5,208 | $29.15 | $152 K | 60,703 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise10b5-1 plan | +43,058 | $20.03 | $862 K | 142,296 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -58,996 | $30.08 | $1.8 M | 83,300 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Sell10b5-1 plan | -10,471 | $29.53 | $309 K | 99,238 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option exercise | +2,014 | — | — | 166,796 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -895 | $27.72 | $25 K | 165,901 | Form 4 |
| filed | Frank Anders WilsonDirector | Option exercise | +6,104 | — | — | 26,460 | Form 4 |
| filed | Shane CookeDirector | Option exercise | +6,104 | — | — | 103,081 | Form 4 |
| filed | Emily Peterson AlvaDirector | Option exercise | +6,104 | — | — | 28,767 | Form 4 |
| filed | Christopher I. WrightDirector | Option exercise | +6,104 | — | — | 15,881 | Form 4 |
| filed | Cato T. LaurencinDirector | Option exercise | +6,104 | — | — | 21,273 | Form 4 |
| filed | David Angelo Daglio Jr.Director | Option exercise | +6,104 | — | — | 29,245 | Form 4 |
| filed | Brian P. McKeonDirector | Option exercise | +6,104 | — | — | 29,245 | Form 4 |
| filed | Richard GaynorDirector | Option exercise | +6,104 | — | — | 26,460 | Form 4 |
| filed | Nancy Lynn SnydermanDirector | Option exercise | +6,104 | — | — | 6,104 | Form 4 |
| filed | Emily Peterson AlvaDirector | Shares withheld for tax | -1,465 | $24.10 | $35 K | 27,302 | Form 4 |
| filed | Nancy Lynn SnydermanDirector | Shares withheld for tax | -1,465 | $24.10 | $35 K | 4,639 | Form 4 |
| filed | David Angelo Daglio Jr.Director | Shares withheld for tax | -1,465 | $24.10 | $35 K | 27,780 | Form 4 |
| filed | Shane CookeDirector | Shares withheld for tax | -3,175 | $24.10 | $77 K | 99,906 | Form 4 |
| filed | Richard GaynorDirector | Shares withheld for tax | -1,465 | $24.10 | $35 K | 24,995 | Form 4 |
| filed | Christopher I. WrightDirector | Shares withheld for tax | -1,465 | $24.10 | $35 K | 14,416 | Form 4 |
| filed | Brian P. McKeonDirector | Shares withheld for tax | -1,465 | $24.10 | $35 K | 27,780 | Form 4 |
| filed | Cato T. LaurencinDirector | Shares withheld for tax | -1,465 | $24.10 | $35 K | 19,808 | Form 4 |
| filed | Frank Anders WilsonDirector | Shares withheld for tax | -1,465 | $24.10 | $35 K | 24,995 | Form 4 |
| filed | Emily Peterson AlvaDirector | Option exercise | +3,871 | — | — | 23,593 | Form 4 |
| filed | Emily Peterson AlvaDirector | Shares withheld for tax | -930 | $23.91 | $22 K | 22,663 | Form 4 |
| filed | Christopher I. WrightDirector | Option exercise | +3,301 | — | — | 10,570 | Form 4 |
| filed | Christopher I. WrightDirector | Shares withheld for tax | -793 | $23.91 | $19 K | 9,777 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Sell10b5-1 plan | -10,417 | $28.10 | $293 K | 65,911 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Sell | -2,559 | $29.65 | $76 K | 7,717 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Option exercise | +6,407 | — | — | 79,173 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise | +2,283 | — | — | 10,948 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Option exercise | +8,737 | — | — | 161,682 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise | +7,689 | — | — | 113,123 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Option exercise | +5,825 | — | — | 118,931 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option exercise | +7,689 | — | — | 168,196 | Form 4 |
| filed | Michael J. LandineSVP, Corp Dev., Alkermes, Inc. | Option exercise | +4,077 | — | — | 283,541 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Shares withheld for tax | -3,414 | $29.57 | $101 K | 109,709 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -3,414 | $29.57 | $101 K | 164,782 | Form 4 |
| filed | Michael J. LandineSVP, Corp Dev., Alkermes, Inc. | Shares withheld for tax | -1,811 | $29.57 | $54 K | 281,730 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Shares withheld for tax | -2,845 | $29.57 | $84 K | 76,328 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Shares withheld for tax | -672 | $29.57 | $20 K | 10,276 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Shares withheld for tax | -3,880 | $29.57 | $115 K | 157,802 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Shares withheld for tax | -2,587 | $29.57 | $76 K | 116,344 | Form 4 |
| filed | Michael J. LandineSVP, Corp Dev., Alkermes, Inc. | Option exercise | +5,654 | — | — | 281,393 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise | +3,114 | — | — | 9,573 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Option exercise | +7,108 | — | — | 75,922 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Option exercise | +7,108 | — | — | 116,262 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Option exercise | +7,431 | — | — | 163,807 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Option exercise | +9,693 | — | — | 157,249 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise | +12,278 | — | — | 110,886 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Shares withheld for tax | -4,304 | $28.91 | $124 K | 152,945 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Shares withheld for tax | -5,452 | $28.91 | $158 K | 105,434 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Shares withheld for tax | -3,156 | $28.91 | $91 K | 72,766 | Form 4 |
| filed | Michael J. LandineSVP, Corp Dev., Alkermes, Inc. | Shares withheld for tax | -1,929 | $28.91 | $56 K | 279,464 | Form 4 |
| filed | David Joseph GaffinEVP, CLO, Alkermes, Inc. | Shares withheld for tax | -3,300 | $28.91 | $95 K | 160,507 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Shares withheld for tax | -908 | $28.91 | $26 K | 8,665 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Shares withheld for tax | -3,156 | $28.91 | $91 K | 113,106 | Form 4 |
| filed | Craig C. HopkinsonEVP R&D, Chief Medical Officer | Option exercise | +10,297 | — | — | 103,180 | Form 4 |
| filed | Iain Michael BrownSVP, Chief Financial Officer | Option exercise | +4,680 | — | — | 110,879 | Form 4 |
| filed | Michael J. LandineSVP, Corp Dev., Alkermes, Inc. | Option exercise | +5,461 | — | — | 277,345 | Form 4 |
| filed | Blair Curtis JacksonEVP, Chief Operating Officer | Option exercise | +4,680 | — | — | 149,634 | Form 4 |
| filed | Samuel Joseph ParisiVP, Finance (Interim PAO) | Option exercise | +1,872 | — | — | 7,100 | Form 4 |
| filed | Christian Todd NicholsSVP, Chief Commercial Officer | Option exercise | +3,901 | — | — | 70,193 | Form 4 |